Heart rate as marker of sympathetic activation in cardiovascular diseases

被引：0
|
作者：
Seravalle, G
Turri, C
Dell'Oro, R
Grassi, G
Mancia, G
机构：
[1] Univ Milan, Osped S Gerardo, Catt Med Interna 1, Monza, Italy
[2] IRCCS, Milan, Italy
[3] Ctr Auxol Italiano, Milan, Italy
来源：
HYPERTENSION | 1998年 / 32卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P69
引用
收藏
页码：614 / 614
页数：1
相关论文
共 50 条
  • [21] Sympathetic cardiovascular activation by modafinil
    Taneja, I
    Diedrich, A
    Black, B
    Maciej, B
    Byrne, D
    Paranjape, SY
    Robertson, D
    HYPERTENSION, 2004, 44 (04) : 522 - 522
  • [22] EFFECTS OF SYMPATHETIC ACTIVATION ON HEART-RATE-VARIABILITY IN CHAGAS PATIENTS
    GUZZETTI, S
    JOSA, D
    PECIS, M
    BONURA, L
    PROSDOCIMI, M
    MALLIANI, A
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1990, 30 : S79 - S82
  • [23] Assessment of heart rate irreversibility induced by graded sympathetic activation in humans
    Casali, Karina Rabello
    Casali, Adenauer Girardi
    Tobaldini, Eleonora
    Gnecchi-Ruscone, Tomaso
    Montano, Nicola
    Porta, Alberto
    FASEB JOURNAL, 2007, 21 (05): : A564 - A564
  • [24] Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
    Grassi, Guido
    Seravalle, Gino
    Vanoli, Jennifer
    Facchetti, Rita
    Spaziani, Domenico
    Mancia, Giuseppe
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (01) : 59 - 67
  • [25] Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
    Guido Grassi
    Gino Seravalle
    Jennifer Vanoli
    Rita Facchetti
    Domenico Spaziani
    Giuseppe Mancia
    Clinical Research in Cardiology, 2023, 112 : 59 - 67
  • [26] Heart rate variability and cardiovascular diseases: A Mendelian randomization study
    Zhao, Yan
    Yu, Hangtian
    Gong, Angwei
    Zhang, Shuaidan
    Xiao, Bing
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023,
  • [27] The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine
    Vizzardi, E.
    Bonadei, I.
    D'Aloia, A.
    Del Magro, F.
    Piovanelli, B.
    Bontempi, L.
    Curnis, A.
    Cas, L. Dei
    MINERVA MEDICA, 2011, 102 (05) : 373 - 379
  • [28] Elevated Heart Rate, A Risk Factor and Risk Marker of Cardiovascular Disease
    Inoue, Taku
    Ohya, Yusuke
    CURRENT HYPERTENSION REVIEWS, 2011, 7 (01) : 29 - 40
  • [29] Resting heart rate and cardiovascular events: risk factor or risk marker?
    Ker, James
    SA PHARMACEUTICAL JOURNAL, 2012, 79 (04) : 45 - 46
  • [30] Resting heart rate and cardiovascular events: risk factor or risk marker?
    Ker, J. A.
    SOUTH AFRICAN FAMILY PRACTICE, 2010, 52 (02) : 128 - 129
12345